top of page
Banner Neil.jpg

Dufton 
Lab

anchor1

Dr Dufton's research centres on the adaptability and plasticity of blood vessels, and particularly the cells that line them, termed endothelial cells are fundamental to both vascular and tissue development, homeostasis and disease pathogenesis. He aims to understand the molecular mechanisms that give rise to disease-associated endothelial phenotypes, such as endothelial-to-mesenchymal transition (EndMT), in models of inflammation and fibrosis. 

Neil has a keen interest communicating his research through art and public engagement projects. These include an interactive game about cell specialisation, I Cell, working with animator (Genetic Moo) to involve participants in Battle of Blister (part of a Wellcome Large arts grant) and knitting blood vessels (Blood Lines). Neil also produces Sciart and has had his images displayed in the National Geographic, the cover of the Journal of Histopathology and has two of his illustrations curated by the Wellcome Image Collection.

Research

Projects

Picture 5
Investigating the diagnostic and drug-screening potential of endothelial-to-mesenchymal transition during liver fibrosis.

Proof-of-Concept Award Emulate-QM Organs-On-Chips Centre. January 2021.

Picture 5
Regulation of vascular patterning via endothelial-to-mesenchymal transition (EndMT) in the pathogenesis of cardiac fibrosis
BHF funded

Project with BHF Mres/PhD Studentship. September 2023-September 2026

Picture 5
Investigating the therapeutic potential of disease-associated endothelial cells in chronic liver disease
Funded by Bart's Charity

In collaboration with Dr William Alazawi (co-applicant), Reader & Consultant in Hepatology at the Blizard Institute, this project aims to assess the prevalence and role of endothelial-to-mesenchymal-transition (EndMT) in patients with non-alcoholic steatohepatitis (NASH). We hypothesis that EndMT is an early, reversible, hallmark of switching from healthy to disease-associated EC that arise during the development of liver disease.

The Dufton group is still recruiting!

Members

Neil Dufton

Neil Dufton

Group Leader

Christina Gkantsinikoudi

Christina Gkantsinikoudi

PhD student

Joshua Dignam

Joshua Dignam

Postdoctoral

Publications

Cytokine-Mediated Degradation of the Transcription Factor ERG Impacts the Pulmonary Vascular Response to Systemic Inflammatory Challenge.

ATVB

Christopher M. Schafer, Silvia Martin-Almedina, Katarzyna Kurylowicz, Neil Dufton, Lourdes Osuna-Almagro, Meng-Ling Wu, Charmain F. Johnson, Aarti V. Shah, Dorian O. Haskard, Andrianna Buxton, Erika Willis, Kate Wheeler, Sean Turner, Magdalena Chlebicz, Rizaldy P. Scott, Susan Kovats, Audrey Cleuren, Graeme M. Birdsey, Anna M. Randi, Courtney T. Griffin.

Placental Inflammation Leads to Abnormal Embryonic Heart Development.

Circulation

Eleanor Ward, Serena Bert, Silvia Fanti, Kerri M Malone, Robert T Maughan, Christina Gkantsinikoudi, Fabrice Prin, Lia Karina Volpato, Anna Paula Piovezan, Gerard J Graham, Neil Dufton, Mauro Perretti, Federica M Marelli-Berg, Suchita Nadkarni. (I Imaged and analysed cardiac vascular development during embryogenesis).

Novel application of live imaging to determine the functional cell biology of Endothelial-to-mesenchymal transition (EndMT) within a Liver-on-a-chip platform.

In Vitro Models

J Whiteford, S Arokiasamy, CL Thompson and NP Dufton*. *Corresponding Author

Cooperative ETS Transcription Factors Enforce Adult Endothelial Cell Physiology and Cardiovascular Homeostasis.

Nature CVR

Gomez-Salinero J, Itkin T, Badwe C, Lin Y, Houghton S, Kunar B, Birdsey G, Kalna V, Dufton N, Peghaire C, Yokoyama M, Wingo M, Li G, Xiang JZ, Hsu Y, Redmond D, Schreiner R, Randi AM, Rafii S.

The transcription factor ERG regulates a low shear stress-induced anti-thrombotic pathway in the microvasculature.

Nature Communications

Peghaire C, Dufton NP, Lang M, Salles-Crawley II, Ahnström J, Kalna V, Raimondi C, Pericleous C, Inuabasi L, Kiseleva R, Muzykantov VR, Mason JC, Birdsey GM and Randi AM.

Dynamic regulation of canonical TGFβ signalling by endothelial transcription factor ERG protects from liver fibrogenesis.

Nature Communications

Dufton NP, Peghaire CR, Osuna-Almagro L, Raimondi C, Kalna V, Chauhan A, Webb G, Yang Y, Birdsey GM, Lalor P, Mason JC, Adams DH and Randi AM.

The endothelial transcription factor ERG mediates Angiopoietin-1-dependent control of Notch signalling and vascular stability.

Nature Communications

Shah AV, Birdsey GM, Peghaire C, Pitulescu ME, Dufton NP, Yang Y, Weinberg I, Osuna Almagro L, Payne L, Mason JC, Gerhardt H, Adams RH and Randi AM.

Molecular dynamics studies on the DNA-binding process of ERG.

Molecular Biosystems

Beuerle MG, Dufton NP, Randi AM and Gould IR.

The endothelial transcription factor ERG promotes vascular stability and growth through Wnt/β-catenin signaling.

Developmental Cell,

Birdsey GM, Shah AV, Dufton N, Reynolds LE, Osuna Almagro L, Yang Y, Aspalter IM, Khan ST, Mason JC, Dejana E, Göttgens B, Hodivala-Dilke K, Gerhardt H, Adams RH and Randi AM.

Hydrogen sulfide and resolution of acute inflammation: A comparative study utilizing a novel fluorescent probe.

Scientific Reports

Dufton N, Natividad J, Verdu EF and Wallace JL.

Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation.

The Journal of Immunology

Dufton N, Hannon R, Brancaleone V, Dalli J, Patel HB, Gray M, D'Acquisto F, Buckingham JC, Perretti M and Flower RJ.

bottom of page